- Corporate Officers - J
- Johnson James A
Insider Trading History of Johnson James A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Johnson James A since 2005.
This trader's CIK number is 1225501.
At the time of last reporting, Johnson James A was the Director of Athira Pharma, Inc.. (stock ticker symbol ATHA).
Also see all insider trading activities at Athira Pharma, Inc..
Note that in the past
JOHNSON JAMES A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nanostring Technologies Inc (NSTG) by Johnson James A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | NSTG | 0 | $0 | 0 | $0 | 3,333 | $0 |
2016 | NSTG | 0 | $0 | 10,000 | $226,055 | 10,000 | $51,199 |
Yearly summary of insider trading at Zymogenetics Inc (ZGEN) by Johnson James A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | ZGEN | 0 | $0 | 20,000 | $195,000 | 20,000 | $55,540 |
2009 | ZGEN | 0 | $0 | 20,000 | $130,000 | 20,000 | $55,560 |
2006 | ZGEN | 0 | $0 | 22,000 | $466,000 | 10,000 | $27,780 |
2005 | ZGEN | 0 | $0 | 3,000 | $54,000 | 0 | $0 |
Yearly summary of insider trading at Athira Pharma, Inc. (ATHA) by Johnson James A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | ATHA | 5,000 | $12,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Johnson James A:
1. Nanostring Technologies Inc (NSTG)
2. Zymogenetics Inc (ZGEN)
3. Athira Pharma, Inc. (ATHA)
Table 1. Insider trading of Nanostring Technologies Inc (NSTG) by Johnson James A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-02-06 | NSTG | Option Ex | 3,333 | .00 | 0 |
2016-11-10 | NSTG | Option Ex | 5,609 | 5.12 | 28,718 |
2016-11-11 | NSTG | Option Ex | 4,391 | 5.12 | 22,481 |
2016-11-10 | NSTG | Sale | 5,609 | 22.61 | 126,819 |
2016-11-11 | NSTG | Sale | 4,391 | 22.60 | 99,236 |
Table 2. Insider trading of Zymogenetics Inc (ZGEN) by Johnson James A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-09-08 | ZGEN | Option Ex | 20,000 | 2.78 | 55,540 |
2010-09-08 | ZGEN | Sale | 20,000 | 9.75 | 195,000 |
2009-12-07 | ZGEN | Option Ex | 10,000 | 2.78 | 27,780 |
2009-12-07 | ZGEN | Sale | 10,000 | 7.00 | 70,000 |
2009-08-31 | ZGEN | Option Ex | 10,000 | 2.78 | 27,780 |
2009-08-31 | ZGEN | Sale | 10,000 | 6.00 | 60,000 |
2006-08-24 | ZGEN | Sale | 3,000 | 20.04 | 60,120 |
2006-03-13 | ZGEN | Sale | 3,000 | 21.75 | 65,250 |
2006-01-12 | ZGEN | Option Ex | 10,000 | 2.78 | 27,780 |
2006-01-12 | ZGEN | Sale | 10,000 | 22.66 | 226,600 |
2006-01-09 | ZGEN | Sale | 3,000 | 20.01 | 60,030 |
2006-01-05 | ZGEN | Sale | 3,000 | 18.00 | 54,000 |
2005-05-17 | ZGEN | Sale | 3,000 | 18.00 | 54,000 |
Table 3. Insider trading of Athira Pharma, Inc. (ATHA) by Johnson James A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-03-29 | ATHA | Buy | 5,000 | 2.40 | 12,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Johnson James A
(Director of Athira Pharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.